HBB

HBB. The HBB gene provides instructions for making one part of hemoglobin, the vital oxygen-transporting protein in red blood cells. Located on the short arm of chromosome 11, it encodes the beta-globin subunit, which pairs with alpha-globin to form functional adult hemoglobin. Mutations in this locus are responsible for some of the most common monogenic disorders worldwide, including sickle cell disease and beta-thalassemia.

Gene and protein structure

The HBB gene resides within the beta-globin gene cluster on chromosome 11, a region tightly regulated by the locus control region. The gene spans approximately 1.6 kilobases and contains three exons and two introns. Its promoter region contains key cis-regulatory elements such as the CACCC box and TATA box, which are binding sites for transcription factors like GATA1 and NF-E2. The mature messenger RNA is translated into a polypeptide of 146 amino acids that folds into a globin protein domain. This structure includes a heme-binding pocket crucial for oxygen binding, formed by a histidine residue known as the proximal histidine.

Function and mechanism

The primary function of the beta-globin protein is to combine with alpha-globin, heme, and iron to form hemoglobin A, the major tetramer in adult erythrocytes. This quaternary structure allows for cooperative oxygen binding and release in the lungs and peripheral tissues, a phenomenon described by the Bohr effect. The allosteric regulation of oxygen affinity is modulated by molecules like 2,3-bisphosphoglycerate produced in the glycolytic pathway. Efficient hemoglobin synthesis is coordinated during erythropoiesis in the bone marrow, requiring balanced production from both the HBB and HBA1/HBA2 genes to prevent the accumulation of unstable globin chains.

Clinical significance

Pathogenic variants in the HBB gene underlie significant global health burdens. The classic example is sickle cell disease, caused by the HbS allele where a glutamic acid-to-valine substitution induces polymerization of deoxyhemoglobin, distorting red blood cells into a sickle shape. This leads to vaso-occlusive crises, hemolytic anemia, and damage to organs like the spleen and kidneys. Another major condition is beta-thalassemia, which results from mutations that reduce or eliminate beta-globin synthesis, causing imbalanced globin chain synthesis, ineffective erythropoiesis, and severe anemia. Management strategies include blood transfusion regimens, iron chelation therapy with agents like deferoxamine, and potentially curative hematopoietic stem cell transplantation.

Genetic variants and hemoglobinopathies

Beyond HbS, hundreds of other HBB variants have been cataloged in databases like HbVar. These include HbC and HbE, which are prevalent in West Africa and Southeast Asia, respectively. The HbC variant causes milder hemolytic anemia, while HbE can lead to a thalassemia phenotype. Beta-thalassemia mutations are classified as beta-zero or beta-plus based on absent or reduced globin output, and often involve point mutations, small deletions, or splicing defects. Compound heterozygosity, such as inheriting HbS and beta-thalassemia (HbS/beta-thalassemia), produces a disease severity spectrum. Population screening programs, such as those recommended by the World Health Organization, and prenatal diagnosis via techniques like chorionic villus sampling are critical for genetic counseling.

Evolutionary history

The HBB gene is part of an ancient globin gene family that evolved from a common ancestor through gene duplication and divergence. The beta-globin gene cluster also contains the developmental genes epsilon-globin and gamma-globin, which are expressed during fetal development under the control of the same locus control region. The persistence of mutations like HbS is explained by balancing selection, where heterozygotes carrying one sickle allele exhibit increased resistance to malaria caused by Plasmodium falciparum, a phenomenon studied extensively in regions like sub-Saharan Africa. Comparative genomics shows the gene's orthologs exist in other vertebrates, with adaptations in oxygen-binding affinity correlating with physiological demands across species.

Category:Human genes Category:Globins